Bandingkan Harga & Kinerja Mitra Investindo Tbk. (MITI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mitra Investindo Tbk. dan Organon Pharma Indonesia Tbk.: Mitra Investindo Tbk. diperdagangkan di Rp286 (kapitalisasi pasar 862,62 M, volume 24 jam 78,12 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mitra Investindo Tbk. jauh lebih besar — sekitar 8,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MITI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 862,62 M | 104,4 M |
Volume | 78,12 jt | — |
Lot | 781,23 rb | — |
Perputaran | 21,33 M | — |
Harga Rata-rata | 272,98 | — |
Nilai Transaksi | 21,33 M | — |
Harga Ekuilibrium Indikatif | 286 | — |
Volume Ekuilibrium Indikatif | 531 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mitra Investindo Tbk.
PT Mitra Investindo Tbk (the Company) was established based on notarial deed No. 280 dated 16 September 1993 of Misahardi Wilamarta, S.H., notary in Jakarta, under the name of PT Minsuco International Finance. The Company's Articles of Association was amended several times, which one of the amendments was based on notarial deed No. 10 dated 15 March 2006 of Amrul Partomuan Pohan, S.H., llm., Notary in Jakarta, concerning the merger of PT Siwani Trinitra Tbk with PT Caraka Berkat Sarana to become PT Mitra Investindo Tbk.
Selengkapnya di halaman MITI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
